HFE gene mutations in a population of Italian Parkinson's disease patients

Ke, 2003, Iron misregulation in the brain: a primary cause of neurodegenerative disorders, Lancet Neurol, 2, 246, 10.1016/S1474-4422(03)00353-3 Berg, 2006, Role of iron in neurodegenerative disorders, Top Magn Reson Imaging, 17, 5, 10.1097/01.rmr.0000245461.90406.ad Gregory, 2005, Neurodegeneration with brain iron accumulation, Folia Neuropathol, 43, 286 Gitlin, 1998, Aceruloplasminemia, Pediatr Res, 44, 271, 10.1203/00006450-199809000-00001 Curtis, 2001, Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease, Nat Genet, 28, 350, 10.1038/ng571 Zhou, 2001, A novel pantothenate kinase gene (PANK2) is defective in Hallervorden–Spatz syndrome, Nat Genet, 28, 345, 10.1038/ng572 LaVaute, 2001, Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice, Nat Genet, 27, 209, 10.1038/84859 Feder, 1996, A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis, Nat Genet, 13, 399, 10.1038/ng0896-399 Demarquay, 2000, Clinical report of three patients with hereditary hemochromatosis and movement disorders, Mov Disord, 15, 1204, 10.1002/1531-8257(200011)15:6<1204::AID-MDS1021>3.0.CO;2-T Berg, 2000, The basal ganglia in haemochromatosis, Neuroradiology, 42, 9, 10.1007/s002340050002 Burdo, 2003, Mechanisms and regulation of transferrin and iron transport in a model blood–brain barrier system, Neuroscience, 121, 883, 10.1016/S0306-4522(03)00590-6 Zecca, 2004, Iron, brain ageing and neurodegenerative disorders, Nat Rev Neurosci, 5, 863, 10.1038/nrn1537 Beutler, 2006, Hemochromatosis: genetics and pathophysiology, Annu Rev Med, 57, 331, 10.1146/annurev.med.57.121304.131310 Nemeth, 2006, Regulation of iron metabolism by hepcidin, Annu Rev Nutr, 26, 323, 10.1146/annurev.nutr.26.061505.111303 Wang, 2004, Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences, J Neurol Sci, 227, 27, 10.1016/j.jns.2004.08.003 Connor, 2006, HFE mutations and Alzheimer's disease, J Alzheimers Dis, 10, 267, 10.3233/JAD-2006-102-311 Borie, 2002, French Parkinson's disease gene tic study group. Association study between iron-related genes polymorphisms and Parkinson's disease, J Neurol, 249, 801 Buchanan, 2002, The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients, Neurosci Lett, 327, 91, 10.1016/S0304-3940(02)00398-1 Dekker, 2003, Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism, Neurosci Lett, 348, 117, 10.1016/S0304-3940(03)00713-4 Guerreiro, 2006, Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort, BMC Neurol, 6, 24, 10.1186/1471-2377-6-24 Akbas, 2006, Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra, Neurosci Lett, 407, 16, 10.1016/j.neulet.2006.07.070 Aamodt, 2007, Prevalence of haemochromatosis gene mutations in Parkinson's disease, J Neurol Neurosurg Psychiatry, 78, 315, 10.1136/jnnp.2006.101352 Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J Neurol Neurosurg Psychiatry, 55, 181, 10.1136/jnnp.55.3.181 Hughes, 2001, Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease, Neurology, 57, 1497, 10.1212/WNL.57.8.1497 Goldwurm, 2006, LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample, Parkinsonism Relat Disord, 12, 410, 10.1016/j.parkreldis.2006.04.001 Fahn, 1987, Unified Parkinson disease rating scale, 153 Hoehn, 1967, Parkinsonism: onset, progression and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427 Sampietro, 2001, The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease, Neurobiol Aging, 22, 563, 10.1016/S0197-4580(01)00219-6 Candore, 2003, Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy, Mech Ageing Dev, 124, 525, 10.1016/S0047-6374(03)00031-9 Cassanelli, 2001, Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy, J Hepatol, 34, 523, 10.1016/S0168-8278(01)00035-6 Biasiotto, 2003, Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individual with biochemical indications of iron overload, Clin Chem, 49, 1981, 10.1373/clinchem.2003.023440 Karimi, 2004, Spectrum and haplotypes of the HFE hemochromatosis gene in Iran: H63D in beta-thalassemia major and the first E277K homozygous, Hematol J, 5, 524, 10.1038/sj.thj.6200553 Bradbury, 2000, Two novel polymorphisms (E277K and V212V) in the haemochromatosis gene HFE, Hum Mutat, 15, 120, 10.1002/(SICI)1098-1004(200001)15:1<120::AID-HUMU32>3.0.CO;2-B